Recent Advances in Perioperative Medicine: Highlights From the Literature for the Cardiothoracic and Vascular Anesthesiologist

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 3, 2009, Pages 430-436

  Augoustides, John G T ^a   Patel, Prakash ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

blockers; endothelins; insulin; pneumonia; renal dysfunction; sodium bicarbonate; statins; steroids; surgical Apgar score; transfusion

Indexed keywords

AMBRISENTAN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; BICARBONATE; BOSENTAN; CEPHALOSPORIN; ENDOTHELIN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; OMEGA 3 FATTY ACID; PLACEBO; SITAXSENTAN; STEROID;

ACUTE LUNG INJURY; ANESTHESIST; ANTIBIOTIC PROPHYLAXIS; AORTA STENOSIS; AORTA VALVE STENOSIS; BETA ADRENERGIC RECEPTOR BLOCKING; BLOOD TRANSFUSION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFECT; EMPYEMA; HEART ARRHYTHMIA; HEART INFARCTION; HEART PROTECTION; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LUNG RESECTION; MEDICAL PRACTICE; MORTALITY; PATIENT CARE; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; PNEUMONIA; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RENAL PROTECTION; REVASCULARIZATION; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; STENT; SURGICAL PATIENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; THORAX SURGERY; TREATMENT OUTCOME; VASCULAR LESION; VASCULAR SURGERY; WOUND INFECTION;

ANESTHESIOLOGY; CARDIOVASCULAR SURGICAL PROCEDURES; HUMANS; PERIOPERATIVE CARE; PHYSICIANS; POSTOPERATIVE COMPLICATIONS;

EID: 67349270531     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.02.005     Document Type: Review

References (50)

1. Chaney M.A. Corticosteroids and cardiopulmonary bypass: A review of clinical investigations. Chest 121 (2002) 921-931
2. Whitlock R.P., Rubens F.D., Young E., et al. Pro: Steroids should be used for cardiopulmonary bypass. J Cardiothorac Vasc Anesth 19 (2005) 250-254
3. Augoustides J.G. Use of corticosteroids to prevent atrial fibrillation after cardiac surgery. JAMA 298 (2007) 283
4. Whitlock R.P., Chan S., Devereaux P.J., et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: A meta-analysis of randomized trials. Eur Heart J 29 (2008) 2592-2600
5. Jadad A.R., Moore R.A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary?. Contol Clin Trials 17 (1996) 1-12
6. Knatterud G.L., Rosenberg Y., Campeau L., et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation 102 (2000) 157-165
7. Chello M., Patti G., Candura D., et al. Effects of atorvastatin on systemic inflammatory response after coronary artery bypass surgery. Crit Care Med 34 (2006) 660-667
8. Collard C.D., Body S.C., Shernan S.K., et al. Preoperative stain therapy is associated with reduced cardiac mortality after coronary artery bypass graft surgery. J Thorac Cardiovasc Surg 132 (2008) 392-400
9. Kulik A., Brookhart M.A., Levin R., et al. Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation 118 (2008) 1785-1792
10. Tabata M., Khalpey Z., Cohn L.H., et al. Effect of preoperative statins in patients without coronary artery disease who undergo cardiac surgery. J Thorac Cardiovasc Surg 136 (2008) 1510-1513
11. Liakopoulos O.J., Choi Y.H., Haldenwang P.L., et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing cardiac surgery: A meta-analysis of over 30 000 patients. Eur Heart J 29 (2008) 1548-1559
12. Downs S.H., and Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomized and nonrandomized studies of health care interventions. J Epidemiol Community Health 52 (1998) 377-384
13. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomized controlled trials: The QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 354 (1999) 1896-1900
14. Stroup D.F., Berlin J.A., Morton S.C., et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting Meta-Analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283 (2000) 2008-2012
15. Gao F., Linhartova L., Johnston A.M., et al. Statins and sepsis. Br J Anaesth 100 (2008) 288-298
16. Multani M.M., Ikonomidis J.S., Kim P.Y., et al. Dynamic and differential changes in myocardial and plasma endothelin in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 129 (2005) 584-590
17. Wei M., Kuukasjarvi P., Laurikka J., et al. Inflammatory cytokines and soluble receptors after coronary artery bypass grafting. Cytokine 15 (2001) 223-228
18. Bittar M.N., Carey J.A., Barnard J.B., et al. Tumor necrosis factor alpha influences the inflammatory response after coronary surgery. Ann Thorac Surg 81 (2006) 132-138
19. Joffs C., Walker C.A., Hendrick J.W., et al. Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass. J Thorac Cardiovasc Surg 122 (2001) 365-370
20. Kirby N.S., Hadoke P.W., Baqnall A.J., et al. The endothelin system as a therapeutic target in cardiovascular disease: Great expectations or bleak house?. Br J Pharmacol 153 (2008) 1105-1119
21. Ford R.L., Mains I.M., Hilton E.J., et al. Endothelin-A receptor inhibition after cardiopulmonary bypass: Cytokines and receptor activation. Ann Thorac Surg 86 (2008) 15767-1583
22. Peltonen T., Taskinen P., Napankangas J., et al. Increase in tissue endothelin-1 and ETA receptor levels in human aortic stenosis. Eur Heart J 30 (2009) 242-249
23. Tourmousoglou C.E., Laios S., and Psarros T. Do statins slow the progression of aortic valve stenosis. Interact Cardiovasc Thorac Surg 7 (2008) 684-689
24. Fleisher L.A., Beckman J.A., Brown K.A., et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: Executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol 50 (2007) 1707-1732
25. Brady A.R., Gibbs J.S., Greenhalgh R.M., et al. Perioperative beta-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trial. J Vasc Surg 41 (2005) 602-609
26. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial). Lancet 371 (2008) 1839-1847
27. Bangalore S., Wetterslev J., Pranesh S., et al. Perioperative beta blockers in patients having non-cardiac surgery: A meta-analysis. Lancet 372 (2008) 1962-1976
28. Lewis S.C., Warlow C.P., et al., GALA Trial Collaborative Group. General anesthesia versus local anaesthesia for carotid surgery (GALA): A multicentre, randomized controlled trial. Lancet 372 (2008) 2132-2142
29. Kasapis C., Henke P.K., Chetcuti S.J., et al. Routine stent implantation vs percutaneous transluminal angioplasty in femoropopliteal artery disease: A meta-analysis of randomized controlled trials. Eur Heart J 30 (2008) 44-55
30. Knaus W.A., Zimmerman J.E., Wagner D.P., et al. APACHE-Acute physiology and chronic health evaluation: A physiologically based classification system. Crit Care Med 9 (1981) 591-597
31. Gawande A.A., Kwaan M.R., Regenbogen S.E., et al. An Apgar score for surgery. J Am Coll Surg 204 (2007) 201-208
32. Regenbogen S.E., Ehrenfeld J.M., Lipsitz S.R., et al. Utility of the surgical Apgar score: Validation in 4119 patients. Arch Surg 144 (2009) 30-36
33. Furnary A.P., Gao G., Grunkemeier G.L., et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 125 (2003) 1007-1021
34. Smith C.E., Styn N.R., Kalhan S., et al. Intraoperative glucose control in diabetic and nondiabetic patients during cardiac surgery. J Cardiothorac Vasc Anesth 19 (2005) 201-208
35. Ascione R., Rogers C.A., Rajakaruna C., et al. Morbidity in diabetic and nondiabetic patients undergoing cardiac surgery. Circulation 118 (2008) 113-123
36. Lecomte P., Van Vlem B., Coddens J., et al. Tight perioperative glucose control is associated with a reduction in renal impairment and renal failure in non-diabetic cardiac surgical patients. Crit Care 12 (2008) R154
37. Polito A., Thiagarajan R.R., Laussen P.C., et al. Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery. Circulation 118 (2008) 2235-2242
38. Arabi Y.M., Dabbagh O.C., Tamim H.M., et al. Intensive versus conventional insulin therapy: A randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 36 (2008) 3190-3197
39. Vlasselaers D., Milants I., Desmet L., et al. Intensive insulin therapy in paediatric intensive care: A prospective, randomized controlled study. Lancet 373 (2009) 547-556
40. Lazar H.L., McDonnell M., Chipkin S.R., et al., The Society of Thoracic Surgeons Practice Guideline Series. Blood glucose management during adult cardiac surgery. Ann Thorac Surg 87 (2009) 663-669
41. Walsh S.R., Tang T.Y., Kullar P., et al. Ischaemic preconditioning during cardiac surgery: Systematic review and meta-analysis of perioperative outcomes in randomized clinical trials. Eur J Cardiothorac Surg 84 (2008) 985-994
42. Wang C., Harris W.S., Chung M., et al. N-3 fatty acids from fish or fish-oil supplements, but not alpha-linoleic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: A systematic review. Am J Clinic Nutr 84 (2006) 5-17
43. Zhao Y.T., Chen Q., Sun Y.X., et al. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary artery disease: A meta-analysis of randomized controlled trials. Ann Med (2009) Jan 16 [Epub ahead of print]
44. GISSI-HF investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF) trial: A randomized, double-blind, placebo-controlled trial. Lancet 372 (2008) 1223-1230
45. McGuiness J., Byrne J., Condron C., et al. Pretreatment with omega-3 fatty acid infusion to prevent leukocyte-endothelial injury responses seen in cardiac surgery. J Thorac Cardiovasc Surg 136 (2008) 135-141
46. Schussler O., Alifano M., Dermine H., et al. Postoperative pneumonia after major lung resection. Am J Respir Crit Care 173 (2006) 1161-1169
47. Schussler O., Dermine H., Alifano M., et al. Should we change antibiotic prophylaxis for lung surgery?. Postoperative pneumonia is the critical issue. Ann Thorac Surg 86 (2008) 1727-1734
48. Marik P.E., and Corwin H.L. Acute lung injury following blood transfusion: Expanding the definition. Crit Care Med 36 (2008) 3080-3084
49. Merten G.J., Burgess W.P., Gray L.V., et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 291 (2004) 2328-2334
50. Haase M., Haase-Fielitz A., Bellomo R., et al. Sodium bicarbonate to prevent increases in serum creatinine after cardiac surgery: A pilot double-blind, randomized controlled trial. Crit Care Med 37 (2009) 39-47